| Literature DB >> 30064509 |
Lara J Cooke1, Diane Duncan2, Laura Rivera2, Shawn K Dowling2, Christopher Symonds3, Heather Armson4.
Abstract
BACKGROUND: Audit and feedback interventions may be strengthened using social interaction. With this in mind, the Calgary office of the Alberta Physician Learning Program developed a process for audit and group feedback for physician groups. As a part of a larger project to develop a practical approach to the design and implementation of audit and group feedback projects, we explored patterns of physician behavior during facilitated audit and group feedback sessions.Entities:
Keywords: Audit and feedback; Feedback; Implementation; Knowledge translation; Physician learning; Practice improvement; Professional development; Social learning theory
Mesh:
Year: 2018 PMID: 30064509 PMCID: PMC6069557 DOI: 10.1186/s13012-018-0796-8
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Fig. 1The CPLP process from clinical question to AGFs. Physician groups bring clinical questions of interest for review by the CPLP. The CPLP team reviews the questions for appropriateness for audit and feedback. Consideration is given to impact, reach, actionability, and accessibility of the data. CPLP collaborates with data custodians to make individualized AF reports for consenting doctors. The confidential reports include individual data with anonymous peer comparators and relevant best practice information. Consenting physicians then participate in a facilitated group feedback session with their peers, led by a CPLP and/or participant facilitator. As a group, the physician peers review each aggregate data point, along with their own performance reports and seek opportunities for practice improvement
Overarching themes, sub-themes, and sub-divisions of the qualitative analysis of six AGFs
| Overarching themes | Sub-themes | Sub-divisions |
|---|---|---|
| Interpreting the data | Reactions | |
| Understanding/questioning | ||
| Justifying/contextualizing | Data is affected by other groups/factors | |
| Data affected by personal factors | ||
| Data affected by patient factors | ||
| Data affected by system factors | ||
| Reflecting | ||
| Understanding evidence about best practices | ||
| Change cues | ||
| Change talk | Actions the group should take | |
| Personal actions a group member will take | ||
| Actions requiring involvement of others/other groups/other professionals |
Representative quotations about interpreting the data
| Sub-theme | |
|---|---|
| Reactions to the data | Satisfaction: case 2C participant |
| “One of my thoughts was … whatever the number is, 5 or 6 people that fall into whichever category. And so now it makes me wonder what did I do there? Cause that 2 from an individual perspective is a very small number. Why did I prescribe and not discontinue? Why did I discontinue and not re-prescribe? Why did I prescribe these drugs rather than those drugs in this particular case? When the absolute number for me as an individual is so small, and I scratch my head about that. So that, it’s fascinating to see where I hit with the rest of everyone else.” | |
| Skepticism: case 1 participant | |
| SPEAKER X: “And I’ll just mention all my 10 patients said not recorded and I never do an IV induction and I’m not sure how that data was…” | |
| Understanding and questioning | Case 2A participant |
| Case 2B: “How did you screen out the group of patients where medications were ordered in your absence, like when the psychiatrist or _____ the orders comes under your name?” | |
| Case 3 participant: “Is this all procedures, is it, ER?” Moderator: “Yes. So again, … All general surgery Yes, so all of the general surgery, so the total number of patients is 716, so this data, … represents 72% of all procedures because those are the cases that were given Ketorolac and then in the chart below, that’s looking at the 512.” Participant: “How do you tease out what’s a general anesthetic and what’s a spinal?...or a regional…” | |
| Justifying/contextualizing | Findings that physicians attributed to the behavior of others |
| Case 1 participant (referring to differences in surgical techniques and surgeons’ practices): “And 25 minutes versus just short of 4 minutes for some of them, as well.” Moderator: “And as well as prescribing when they are home. Some [surgeons] never give morphine. Some will only give, like, Tylenol or something. Some will give oral morphine. So, it’s not surprising pain scores vary.” | |
| Findings that result from external factors (caring for hospice patients in this example): case 2A | |
| Moderator: “So again, on the other hand you can see this person out here is probably a better example, saw lots of patients, 35, and half of them got either an antipsychotic or a sedative...” Speaker 1: “... So that’s probably where my midazolam comes from. Because we use tons of midazolam, Haldol, and stuff on hospice.” | |
| Findings that physicians attributed to personal practices | |
| Case 2A participant: (discussing why order a zopiclone on admission): “So, cause one of the things … I try to anticipate the calls I am going to have when I am the ward doctor, and try to prevent those. One of those is zopiclone.” | |
| Case 3 participant (discussing use of ketamine for pain control intra-operatively): “I was using it for a while just to, my numbers are actually very low cause I used it for a while and then I got to know the surgeons and realized that for the most part, I know which ones are really good at [inaudible] filtration and the patients are waking up very comfortable, they are actually not requiring a lot of opioids, so then I did not feel like they needed the Ketamine.” | |
| Findings that physicians attributed to patient factors | |
| Case 2A participant: “Let us say when I look at my own it’s the same thing. I see drugs on mine that I am like, I can use that once a year. Like chlorpromazine, I guarantee you it’s because somebody had hiccups from something and I gave them chlorpromazine. I never use that drug.” | |
| Case 2B participant: “There is a subtly different patient population as well. [Hospital D] is quite a bit older than [Hospital B].” | |
| Case 2C participant: “I do not know, I do not know if it would, if the numbers would be large enough to have separate graphs for antipsychotics and sedatives. Sedatives like specifically zopiclone, just because probably the populations that would use those 2 medications are different. You know, just for your sleep, difficulty sleeping in hospital, versus dementia with behavioural issues for antipsychotics.” | |
| Findings that physicians attributed to system factors: | |
| Case 2A | |
| Speaker 1 participant “The fall of 2013, was that our Ativan shortage too? Because that will tie in….Because that’ll factor into this, too, because we were ordering goofy things because we could not get the stuff we usually would use. Because that lovely plant in Quebec was down for so long. …Yeah, but midazolam is only IV. So, I used it to substitute for [IV] Ativan in a few people at times.” | |
| Case 2D participant: “Maybe not that the patients that we see here are different, but our prescribing practices might be influence by like the consultants that we work with in this hospital, or the particular group that we work within.” | |
| Reflecting | Case 1: Participants sharing their practices (discussing the use of nitrous in anesthesia in children): Speaker 1 “[NAME] tried it, without nitrous. I made a switch. Your induction. If that’s your induction try doing it without. Because traditionally we did it when this apoptosis came out I decided to delete nitrous from my practice. So, I have zero for induction. And I haven’t really noticed that longer an induction”. Speaker 2 “I don’t use it either.” Speaker 1 “In fact, I don’t notice a longer induction time actually. So, you might be saving 30 s or something. I haven’t documented it. But it’s something you could try to avoid having to push a button and remembering one more button. Just use air oxygen.” |
Representative examples of physicians discussing evidence during AGFs
| Discussing evidence for best practices | Representative quotations |
|---|---|
| Case 2B | Participant [raising recent guidelines for the group]. “There’s a bunch of new Choosing Wisely recommendations that came out not last week but the week before. And under the psychiatrists’ [Choosing Wisely Recommendations] there’s a number of them deal with antipsychotics as well, too.” |
| Case 3 | Participant [discussing safety of steroids in diabetic patients]: “And another thing about Dexamethasone… there was a study that showed the glucose jump after single dose of in diabetic is not actually more than, you know, in normal non-diabetic. So, unless it’s a [inaudible] insulin and, you know, with complications, I use it on diabetics too because it’s [inaudible] oral hypoglycemics so it’s, apparently, it’s not affected, like they are not getting the coma after this single dose of Dexamethasone.” |
Representative examples of change cues and change talk during AGFs
| Representative quotation | |
|---|---|
| Change cue and ensuing change talk | Case 2A participant (discussing data on sedatives and anti-psychotics in the elderly): “… we need support and the region sometimes are not thinking about, so we are all going to have to commit to better, … make sure we are not ordering vitals or meds at night. There’s one. It’s a big one to just keep in our head once in a while, once a week, to just check that.” |
| Case 2A: In response to the change cue above, participants offered to take leadership on and identify specific action items to address prescribing of sedatives: Speaker 1: “This is a QI project, I can take that one.” Speaker 2: “I just feel like it will need some sustained attention. Otherwise, it’ll be just one of many CMEs we have had all year. I think it’s important.” Speaker 1: “Then can I hear from this group one list of 3 recommendations that I can take down to the group. Three easy to remember QI things that I can do as a whole and email everybody.” | |
| Change cue and ensuing change talk | A group participant in an anesthesia study identified a priority issue in clear language: Case 1: Speaker 1: “Our biggest problem post-op is pain.” Speaker 2: “Yeah, it is.” Speaker 1: “If you look at the data. So if we can improve intra-operative management by ketamine it would change my practice.” Speaker 2: “Without jeopardizing the nausea and vomiting.” |
| Change cue without change talk | A group member identifies a key issue and the facilitator moves on to the next topic to explain in the individual data reports. No change talk occurs: Speaker 1: “So this is a really important thing that are resulting in increased usage of sedative, which is really the point, right |
| Facilitator | |
| “…That’s, I think, the whole idea behind this kind of education, right? Okay, well let us go over the individual. And we can always come back at any time to anything else that needs clarification. So, as I said, we limited docs that got included in this to those that had at least 10 visits…” |
Fig. 2Conceptual model of the cycle of physician behaviors in AGFs. During AGFs, as each new data point was reviewed by the group, physicians progressed through this complement of behaviors, beginning with reactions, then questioning and understanding, and reflection. Opportunities to react to data and address data limitations, skepticism, and surprise would be followed by efforts to understand the AF reports and tables. These steps were necessary pre-requisites to reflection, which included group discussions of individual practice patterns, variations, and experiences as well as guidelines and clinical best practices. Emergent from reflection would be change cues raised by group members. Change cues would routinely pivot the discussion towards action planning. The cycle would repeat with each new data point discussion over the course of the AGF